Achilles Tendon Rupture Patient Outcomes at 12 Months
ATR-12
What Are the Isokinetic Strength Outcomes and Self-reported Functional Outcomes (ATRS) at 12 Months Following Non-surgical Management of Achilles Tendon Rupture Using the SMART Protocol?
2 other identifiers
observational
115
1 country
2
Brief Summary
The Achilles tendon is the strongest and largest tendon in the human body, playing a critical role in plantarflexion and facilitating activities such as walking, running, and jumping. However, it is also the most frequently ruptured tendon. The injury and associated disability have a significant impact on patient quality of life and healthcare services. Achilles tendon ruptures are increasingly common, particularly among middle-aged recreational athletes, with an incidence estimated at 18 per 100,000 person-years. The Swansea Morriston Achilles Rupture Treatment (SMART) protocol represents a structured, progressive approach to non-operative rehabilitation. It emphasizes early mobilization, protected weight-bearing, and a gradual return to sport or high-level function through targeted strength and neuromuscular training. While short-term outcomes of non-surgical protocols have demonstrated promising results, there remains limited high-quality data on long-term isokinetic strength and patient-reported functional outcomes beyond six months in this patient group. This study aims to evaluate isokinetic plantarflexor strength and self-reported functional outcomes at 12 months following non-surgical management of Achilles tendon ruptures using the SMART rehabilitation protocol. By assessing both objective and subjective recovery metrics, we aim to contribute to the growing evidence base for evidence-informed, conservative Achilles tendon rehabilitation. A secondary aim of the study is to examine the relationship between isokinetic strength scores and self reported functional recovery scores using the ATRS questionnaire. Participants will attend one 60-90 minute visit to complete a short questionnaire and perform a safe, clinic-based ankle strength test using an isokinetic machine; the test feels like pushing against a footplate, similar to resisted ankle movements. The results of these tests will be collected and analysed. The study will help to gain further insight into patient recovery from this injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2026
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
Study Completion
Last participant's last visit for all outcomes
January 1, 2029
March 3, 2026
February 1, 2026
2 years
January 25, 2026
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Peak Plantarflexion Torque (Nm)
Maximum rotational force produced by the plantarflexor muscles during an isokinetic concentric contraction, measured using an isokinetic dynamometer. This measure reflects calf muscle strength and tendon function following non-surgical Achilles tendon rupture management.
12-15 months post-injury (single study visit)
Peak Plantarflexion Torque Normalized to Bodyweight (Nm/kg)
Peak plantarflexion torque adjusted for each participant's bodyweight. Normalisation allows strength comparisons between individuals of different body sizes and provides a more functional evaluation of recovery.
12-15 months post-injury (single study visit)
Limb Symmetry Index (LSI) for Peak Torque (%)
Ratio of injured limb peak plantarflexion torque to the uninjured limb, expressed as a percentage. An LSI ≥90% is typically considered indicative of satisfactory recovery.
12-15 months post-injury (single study visit)
Achilles Tendon Total Rupture Score
A validated patient-reported outcome measure assessing symptoms and functional limitations following Achilles tendon rupture. Scores range from 0 to 100, with higher scores indicating better perceived recovery.
12-15 months post-injury (single study visit)
Secondary Outcomes (1)
Correlation Between Isokinetic Strength Measures and Achilles Tendon Total Rupture Score
12-15 months post-injury (single study visit)
Study Arms (1)
Non-Surgically Managed Achilles Tendon Rupture Cohort
Adults who sustained an Achilles tendon rupture and were managed non-surgically using the SMART rehabilitation protocol within Liverpool University Hospitals NHS Foundation Trust. All participants are 12-15 months post-injury at the time of assessment.
Interventions
Participants previously received standard non-surgical treatment for Achilles tendon rupture following the SMART (Swansea Morriston Achilles Rupture Treatment) functional rehabilitation protocol as part of routine NHS care. No interventions are assigned as part of this study; all data are collected at a single follow-up visit.
Eligibility Criteria
Adults who previously sustained an Achilles tendon rupture and were treated non-surgically using the SMART rehabilitation protocol within Liverpool University Hospitals NHS Foundation Trust. Eligible participants are identified from an existing clinical database and represent patients 12-15 months post-injury who completed standard physiotherapy rehabilitation. All participants are drawn from routine NHS orthopaedic and physiotherapy services at Aintree and Broadgreen Hospitals.
You may qualify if:
- Adults aged 18 years or older at the time of recruitment.
- Confirmed diagnosis of Achilles tendon rupture, diagnosed clinically and recorded within the NHS database.
- Injury managed non-surgically using the SMART (Swansea Morriston Achilles Rupture Treatment) protocol.
- months post-injury at the time of assessment.
- Able and willing to provide informed written consent to participate in the study.
You may not qualify if:
- Unable to provide informed consent.
- Previous surgical repair of the Achilles tendon or documented re-rupture.
- Presence of a neuromuscular disorder affecting lower limb strength or function.
- Did not follow the SMART protocol for non-surgical management.
- History of Achilles tendinopathy or rupture in the contralateral (uninjured) leg.
- Unable to tolerate isokinetic strength testing due to pain, discomfort, or other medical reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Broadgreen Hospital Physiotherapy department
Liverpool, Merseyside, L14 3LB, United Kingdom
Aintree University Hospital Therapies department
Liverpool, Merseyside, L9 7 AL, United Kingdom
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Jeff Morton, BSc. (Hons) Physiotherapy
Liverpool University Hospitals NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Physiotherapist
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 6, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
January 1, 2029
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. Only aggregated, anonymised results will be published. This is consistent with participant consent and NHS data governance requirements